Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Pharmacological Reviews
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Pharmacological Reviews

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit Pharm Rev on Facebook
  • Follow Pharm Rev on Twitter
  • Follow ASPET on LinkedIn

Index by author

June 01, 1984; Volume 36,Issue 2
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

B

  1. Bardin, C W

    1. You have access
      Steroid receptors and hormone action: physiological and synthetic androgens and progestins can mediate inappropriate biological effects.
      O A Jänne and C W Bardin
      Pharmacological Reviews June 1984, 36 (2) 35S-42S;
  2. Barrett, J C

    1. You have access
      Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis.
      J C Barrett, T W Hesterberg and D G Thomassen
      Pharmacological Reviews June 1984, 36 (2) 53S-70S;
  3. Bresnick, E

    1. You have access
      Induction of cytochrome P450 by xenobiotics.
      E Bresnick, R Foldes and R N Hines
      Pharmacological Reviews June 1984, 36 (2) 43S-51S;

C

  1. Chang, C C

    1. You have access
      Adaptive and nonadaptive consequences of chemical inhibition of intercellular communication.
      J E Trosko and C C Chang
      Pharmacological Reviews June 1984, 36 (2) 137S-144S;
  2. Chytil, F

    1. You have access
      Retinoic acid: biochemistry, pharmacology, toxicology, and therapeutic use.
      F Chytil
      Pharmacological Reviews June 1984, 36 (2) 93S-100S;

D

  1. Doull, J

    1. You have access
      The past, present, and future of toxicology.
      J Doull
      Pharmacological Reviews June 1984, 36 (2) 15S-18S;

E

  1. Engelberg, H

    1. You have access
      Heparin and the atherosclerotic process.
      H Engelberg
      Pharmacological Reviews June 1984, 36 (2) 91-110;
  2. Enslein, K

    1. You have access
      Estimation of toxicological endpoints by structure-activity relationships.
      K Enslein
      Pharmacological Reviews June 1984, 36 (2) 131S-135S;

F

  1. Farber, J L

    1. You have access
      Mechanisms of cell injury with hepatotoxic chemicals.
      J L Farber and R J Gerson
      Pharmacological Reviews June 1984, 36 (2) 71S-75S;
  2. Fariss, M W

    1. You have access
      Glutathione depletion and susceptibility.
      D J Reed and M W Fariss
      Pharmacological Reviews June 1984, 36 (2) 25S-33S;
  3. Fernandes, G

    1. You have access
      Nutritional factors: modulating effects on immune function and aging.
      G Fernandes
      Pharmacological Reviews June 1984, 36 (2) 123S-129S;
  4. Foldes, R

    1. You have access
      Induction of cytochrome P450 by xenobiotics.
      E Bresnick, R Foldes and R N Hines
      Pharmacological Reviews June 1984, 36 (2) 43S-51S;

G

  1. Gerson, R J

    1. You have access
      Mechanisms of cell injury with hepatotoxic chemicals.
      J L Farber and R J Gerson
      Pharmacological Reviews June 1984, 36 (2) 71S-75S;
  2. Gilfillan, A M

    1. You have access
      The pharmacology of lung surfactant secretion.
      M Hollingsworth and A M Gilfillan
      Pharmacological Reviews June 1984, 36 (2) 69-90;
  3. Goldberg, A M

    1. You have access
      Approaches to the development of in vitro toxicological methods.
      A M Goldberg
      Pharmacological Reviews June 1984, 36 (2) 173S-175S;
  4. Grisham, J W

    1. You have access
      Predictive and mechanistic evaluation to toxic responses in mammalian cell culture systems.
      J W Grisham and G J Smith
      Pharmacological Reviews June 1984, 36 (2) 151S-171S;

H

  1. Hesterberg, T W

    1. You have access
      Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis.
      J C Barrett, T W Hesterberg and D G Thomassen
      Pharmacological Reviews June 1984, 36 (2) 53S-70S;
  2. Hines, R N

    1. You have access
      Induction of cytochrome P450 by xenobiotics.
      E Bresnick, R Foldes and R N Hines
      Pharmacological Reviews June 1984, 36 (2) 43S-51S;
  3. Hollingsworth, M

    1. You have access
      The pharmacology of lung surfactant secretion.
      M Hollingsworth and A M Gilfillan
      Pharmacological Reviews June 1984, 36 (2) 69-90;
  4. Hostetter, T H

    1. You have access
      Progressive glomerular injury: roles of dietary protein and compensatory hypertrophy.
      T H Hostetter
      Pharmacological Reviews June 1984, 36 (2) 101S-107S;

J

  1. James, J L

    1. You have access
      Irreversible cell injury.
      E A Smuckler and J L James
      Pharmacological Reviews June 1984, 36 (2) 77S-91S;
  2. Jänne, O A

    1. You have access
      Steroid receptors and hormone action: physiological and synthetic androgens and progestins can mediate inappropriate biological effects.
      O A Jänne and C W Bardin
      Pharmacological Reviews June 1984, 36 (2) 35S-42S;

R

  1. Rando, R R

    1. You have access
      Mechanism-based enzyme inactivators.
      R R Rando
      Pharmacological Reviews June 1984, 36 (2) 111-142;
  2. Reed, D J

    1. You have access
      Glutathione depletion and susceptibility.
      D J Reed and M W Fariss
      Pharmacological Reviews June 1984, 36 (2) 25S-33S;
  3. Roe, D A

    1. You have access
      Therapeutic significance of drug-nutrient interactions in the elderly.
      D A Roe
      Pharmacological Reviews June 1984, 36 (2) 109S-122S;

S

  1. Sadler, T W

    1. You have access
      Use of whole embryo culture for evaluating toxicity and teratogenicity.
      T W Sadler and C W Warner
      Pharmacological Reviews June 1984, 36 (2) 145S-150S;
  2. Schach von Wittenau, M

    1. You have access
      Whole animal models in safety evaluation.
      M Schach von Wittenau
      Pharmacological Reviews June 1984, 36 (2) 177S-182S;
  3. Shank, R C

    1. You have access
      Toxicity-induced aberrant methylation of DNA and its repair.
      R C Shank
      Pharmacological Reviews June 1984, 36 (2) 19S-24S;
  4. Smith, G J

    1. You have access
      Predictive and mechanistic evaluation to toxic responses in mammalian cell culture systems.
      J W Grisham and G J Smith
      Pharmacological Reviews June 1984, 36 (2) 151S-171S;
  5. Smuckler, E A

    1. You have access
      Irreversible cell injury.
      E A Smuckler and J L James
      Pharmacological Reviews June 1984, 36 (2) 77S-91S;

T

  1. Thomassen, D G

    1. You have access
      Use of cell transformation systems for carcinogenicity testing and mechanistic studies of carcinogenesis.
      J C Barrett, T W Hesterberg and D G Thomassen
      Pharmacological Reviews June 1984, 36 (2) 53S-70S;
  2. Trosko, J E

    1. You have access
      Adaptive and nonadaptive consequences of chemical inhibition of intercellular communication.
      J E Trosko and C C Chang
      Pharmacological Reviews June 1984, 36 (2) 137S-144S;

W

  1. Warner, C W

    1. You have access
      Use of whole embryo culture for evaluating toxicity and teratogenicity.
      T W Sadler and C W Warner
      Pharmacological Reviews June 1984, 36 (2) 145S-150S;
Back to top
PreviousNext

In this issue

Pharmacological Reviews
Vol. 36, Issue 2
1 Jun 1984
  • Table of Contents
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Nitric oxide: physiology, pathophysiology, and pharmacology.
  • The Glutamate Receptor Ion Channels
  • Receptors for Purines and Pyrimidines
  • Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling
  • Glutamate Receptor Ion Channels: Structure, Regulation, and Function
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Pharmacological Reviews
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacology Research & Perspectives
ISSN 1521-0081 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics